Page last updated: 2024-08-25

bendamustine hydrochloride and DDD MPGNII

bendamustine hydrochloride has been researched along with DDD MPGNII in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartel, C; Geiger, H; Hauser, IA; Obermüller, N; Rummel, MJ	1

Other Studies

1 other study(ies) available for bendamustine hydrochloride and DDD MPGNII

Article	Year
Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine. Clinical nephrology, 2008, Volume: 69, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Humans; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nephrotic Syndrome; Nitrogen Mustard Compounds; Remission Induction; Rituximab	2008

Article

Year

Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.

Clinical nephrology, 2008, Volume: 69, Issue:4

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Humans; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nephrotic Syndrome; Nitrogen Mustard Compounds; Remission Induction; Rituximab

2008